Shares of Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report) passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $10.18 and traded as low as $7.4701. Ampliphi Biosciences shares last traded at $8.12, with a volume of 67,386 shares traded.
Ampliphi Biosciences Stock Performance
The firm has a 50-day moving average price of $10.18 and a 200-day moving average price of $8.17.
About Ampliphi Biosciences
Ampliphi Biosciences, Inc is a clinical‐stage biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the discovery and development of novel therapies to prevent and treat life‐threatening drug‐resistant infections. The company’s core mission is to address the growing global threat of antibiotic resistance by advancing first‐in‐class and best‐in‐class antibacterial agents through late‐stage clinical trials.
The company’s lead product candidate, exeporfinium chloride (XF-73), is a pioneering topical antibacterial designed for pre‐operative nasal decolonization of Staphylococcus aureus in patients undergoing high‐risk surgical procedures.
Recommended Stories
- Five stocks we like better than Ampliphi Biosciences
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
